Electronics and Semiconductor
Aerospace and Defense
Automotive and Transportation
Biotechnology
Chemicals and Materials
Consumer Goods
Energy and Power
Food and Beverages
Healthcare IT
Information & Communications
Manufacturing and Construction
Packaging
Pharmaceuticals
Market Summary
The global Elastomeric Infusion Pumps Market size was valued at USD 1.35 billion in 2025 and is projected to reach USD 3.1 billion by 2033, growing at a CAGR of 9.90% from 2026 to 2033.
Elastomeric infusion pumps are referred to as single-use, disposable infusion pumps applied in the infusion of medications such as antibiotics, chemotherapy, and pain management medications. Currently, the different healthcare systems are prioritizing and concentrating their efforts on offering home-based and outpatient services in efforts to avoid the ever-increasing costs of staying in the hospitals considerably. According to the World Health Organization (WHO), the application of home-based healthcare services helps to considerably decrease the instances of readmissions and the associated costs of the healthcare organizations. Although it requires no power and no complex programming for continuous infusion, many patients will require the use of the elastomeric infusion pumps and allow the treatment to be carried out in the hospital or at the outpatient institution, which entails getting admitted or spending the entire day in the facility. One of the greatest benefits of the application of elastomeric infusion pumps is offering comfort as well as decreased infection rates associated with infections from the hospital and the ability to offer capacity to the organizations. As stated by the Centers for Disease Control and Prevention, it is estimated that 1 out of 31 patients within a hospital setting will present with at least one HAI. Thus, the need for home-based clinical care is fueling the growth of the Elastomeric Infusion Pumps Market place.
Market Size & Forecast
- 2025 Market Size: USD 1.35 Billion
- 2033 Projected Market Size: USD 3.1 Billion
- CAGR (2026-2033): 9.90%
- North America: Largest Market in 2026
- Asia Pacific: Fastest Growing Market
To learn more about this report, 
Download Free Sample Report
Key Market Trends Analysis
- Steady Market Expansion: The elastomeric infusion pumps market is growing consistently, with forecasts showing strong compound annual growth through the late 2020s and early 2030s as demand rises for reliable drug-delivery systems.
- Rising Prevalence of Chronic Diseases: Increasing incidence of cancer, diabetes, and cardiovascular diseases around the world is increasing demand and hence driving growth, as most chronic conditions necessitate continuous infusion therapy.
- Ambulatory & Home Care: Increased adoption of portable elastomeric pumps in ambulatory surgical centers and home care settings is the result of a patient preference for more convenient and comfortable treatments outside traditional hospitals.
- The ongoing technological innovation is improving the designs of the pumps, their safety features, and materials to enhance usability, accuracy, and comfort for the patients; thereby, doctors' prescriptions could easily advocate the wider diffusion of CID in both clinical and home settings.
- Regional Growth Patterns: While North America remains the biggest regional market in advanced healthcare infrastructure and aging populations, Asia-Pacific has emerged as one of the fastest growing markets in recent years with its expanding healthcare investment and rising volume of surgical activity.
Elastomeric Infusion Pumps Market Segmentation
By Product
- Continuous rate
Continuous rate elastomeric infusion pumps are widely used, which gives them the leading position in the market today. These are preferable in pain management, chemotherapy, and antibiotic therapies requiring consistent dosing, since they deliver medicines at a fixed, steady flow.
- Variable Rate
Variable rate pumps are gaining traction on the global market because they enable setting the flow rate depending on the requirements for specific treatment. It therefore offers greater flexibility in therapies that are complex and can be implemented safely both in the hospital and home-care settings.
To learn more about this report, Download Free Sample Report
By Application
- Pain Management
The pain management application is the largest segment worldwide because elastomeric infusion pumps enable constant and regulated pain reliever administration for post-operative pain management and chronically suffering pain patients.
- Chemotherapy
Use of chemotherapy is on the increase due to the availability of pumps that enable accurate ambulatory drug administration. This improves comfort for patients.
- Antibiotic/Antiviral Therapy
Such pumps are capable of supporting antibiotics and antiviral therapies in such a manner as to enable outpatient treatment.
- Others
The other uses of infusion solutions are hydration therapy, cardiovascular medications, and specialty medications, which help in increasing the market size due to their versatility and portability options.
By End-user
- Hospitals
These institutions continue to be the chief users of elastomeric infusion pumps, particularly in the controlled administration of medications in the post-operative and inpatient care settings.
- Ambulatory surgical centers
These institutions have started quickly adopting pumps because they can be moved easily. This allows more surgeries to take place on an outpatient basis.
- Others
Other end-users, like home healthcare and specialty clinics, offer potential avenues of increased usage as they help facilitate consistent therapies in a home healthcare setup and remote environments.
Regional Insights
Globally, the North American region has been leading the elastomeric infusion pumps market, following advancements in the healthcare infrastructure, widespread adoption of ambulatory and home-care therapies, and the huge patient base demanding the management of chronic illnesses. The European market is a strong one, owing to the established healthcare infrastructure, in addition to the increasing focus on the management of pain using ambulatory care solutions. The Asia-Pacific market is the most rapidly expanding one, owing to the increasing investments in the healthcare infrastructure, combined with the growing perception about the use of ambulatory infusion therapies in countries such as China, Japan, and the Indian subcontinent. The Latin American and Middle Eastern countries, along with the African nations, are creating new routes in the emerging market.
To learn more about this report, Download Free Sample Report
Recent Development News
- In April 2025, ICU Medical announced the launch of a new category of infusion devices following the U.S. FDA clearances of its Plum Solo™ and Plum Duo™ precision IV pumps. The company stated that these next-generation pumps were designed to enhance accuracy, workflow efficiency, and patient safety in both hospital and outpatient settings.
- In November 2024, Avanos Medical announced that its ON-Q elastomeric infusion pump, along with the ambIT electronic infusion pump, qualified for separate Medicare reimbursement under the NOPAIN Act, effective January 1, 2025.
|
Report Metrics |
Details |
|
Market size value in 2025 |
USD 1.35 Billion |
|
Market size value in 2026 |
USD 1.6 Billion |
|
Revenue forecast in 2033 |
USD 3.1 Billion |
|
Growth rate |
CAGR of 9.90% from 2026 to 2033 |
|
Base year |
2025 |
|
Historical data |
2021 – 2024 |
|
Forecast period |
2026 – 2033 |
|
Report coverage |
Revenue forecast, competitive landscape, growth factors, and trends |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
United States; Canada; Mexico; United Kingdom; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; United Arab Emirates |
|
Key company profiled |
ACE Medical, Ambu, Avanos, B. Braun, Baxter, Fresenius Kabi, Halyard, ICU Medical, JMS, KB Medical, Leventon, Nipro, Smiths Medical, Terumo, Woo Young Medical |
|
Customization scope |
Free report customization (country, regional & segment scope). Avail customized purchase options to meet your exact research needs. |
|
Report Segmentation |
By Product (Continuous Rate, Variable Rate), By Application (Pain Management, Chemotherapy, Antibiotic/Antiviral Therapy, Others), By End-Use (Hospitals, Ambulatory Surgical Centers, Others) |
Key Elastomeric Infusion Pumps Company Insights
With its broad portfolio-including IoT-enabled precision equipment, autonomous machinery, and data analytics platforms-Deere & Company is a clear market leader. Its global presence and significant investment in research and development allow the company to continue to innovate, providing scalable solutions for farmers that help improve operational efficiency and sustainability. Deere's ability to integrate hardware and software ecosystems provides a competitive advantage, which fosters wide diffusion across large commercial farms worldwide.
Key Elastomeric Infusion Pumps Companies:
- ACE Medical
- Ambu
- Avanos
- Braun
- Baxter
- Fresenius Kabi
- Halyard
- ICU Medical
- JMS
- KB Medical
- Leventon
- Nipro
- Smith’s Medical
- Terumo
- Woo Young Medical
Global Elastomeric Infusion Pumps Market Report Segmentation
By Product
- Continuous Rate
- Variable Rate
By Application
- Pain Management
- Chemotherapy
- Antibiotic/Antiviral Therapy
- Others
By End-user
- Hospitals
- Ambulatory Surgical Centers
- Others
Regional Outlook
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- Japan
- China
- Australia & New Zealand
- South Korea
- India
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of the Middle East & Africa
APAC:+91 7666513636
